FACT: That claim is outdated, misleading, and based on decade-old data from before opioid prescribing sharply declined in the U.S.

The “80%/99%” figures come from a 2011 INCB report using 2010 data, long before the CDC guidelines, DEA crackdowns, and massive prescribing reductions. It’s been repeated ever since to shame doctors, vilify pain patients, and justify restrictive policies, without context or accuracy.

What the Evidence Shows

• U.S. prescribing has dropped over 60% since 2011. CDC data shows prescriptions fell from 255 million in 2012 to about 125 million in 2023.
  
• The 80% figure reflects inequality, not excess. Most of the world can’t access opioids even for cancer or end-of-life pain.
  
• Hydrocodone was mostly an American drug. Until 2014, it was Schedule III, easier to prescribe, while most countries used morphine or codeine instead.
  
• Global opioid access is deeply unequal. The 2017 Lancet Commission found the poorest 50% of people receive only 1% of the world’s morphine supply.
  
• Using these stats today is dishonest. They ignore major declines in U.S. prescribing and the global pain-relief gap.
  

Why It Matters

Repeating the “80% of the world’s opioids” myth creates a false picture of American excess while hiding a humanitarian crisis: most of the world’s population suffers with untreated pain.

This outdated statistic has been used to justify forced tapers, criminalize prescribers, and block access to legitimate care, hurting patients instead of helping them.

The Real Story

U.S. prescribing has plummeted, hydrocodone use has collapsed, and overdose deaths are now driven by illicit fentanyl, not prescription medicine. The real issue isn’t “overuse in America,” it’s under-access everywhere else.

For the full analysis, data sources, and printable fact sheets, visit our Patreon page.